Skip to main content

Animations

MJFF Publications

3061 - 3070 of 6284 Results
Title
Year
  • Year
  • 2011
  • 2011
  • 2012
  • 2016
  • 2009
  • 2017
  • 2016
  • 2016
  • 2018
  • 2016
  • Summary Details
    OPEN
    Title: Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice
    Journal Name: Molecular and Cellular Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.mcn.2011.05.006
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Parkinson's disease, cortical dysfunction, and alpha‐synuclein
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23697
    Citation Count: 23
  • Summary Details
    OPEN
    Title: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function
    Journal Name: The Journal of Rehabilitation Research and Development
    Publisher: Journal of Rehabilitation Research & Development
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103
    Best OA location URL:
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Impaired perception of biological motion in Parkinson’s disease.
    Journal Name: Neuropsychology
    Publisher: American Psychological Association (APA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1037/neu0000276
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020
    Citation Count: 46
  • Summary Details
    OPEN
    Title: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0007-3
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working Memory
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2016.14
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum Disorder
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/npp.2016.64
    Citation Count: 145
  • Summary Details
    OPEN
    Title: mGlu1 and mGlu5 modulate distinct excitatory inputs to the nucleus accumbens shell
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41386-018-0049-1
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/npjparkd.2015.27
    Citation Count: 71
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.